Safety and Efficacy Study of IV Artesunate to Treat Malaria
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine how GMP IV Artesunate is metabolized and cleared by
individuals with uncomplicated malaria infection and to determine how fast it eliminates
malaria infection from the body.
Phase:
Phase 2
Details
Lead Sponsor:
U.S. Army Medical Research and Development Command U.S. Army Office of the Surgeon General
Collaborator:
Military Infectious Diseases Research Program (MIDRP)
Treatments:
Artemisinins Artesunate Atovaquone Atovaquone, proguanil drug combination Proguanil Quinidine